Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Our overarching goal is to improve the outcomes of critically ill COVID-19 patients with or
at risk for development of acute kidney injury (AKI). The objective of this study is to
determine the role of a protocol to manage urine alkalization using a simple medication that
has been used for a very long time, is safe, and without significant side-effects. We aim to
determine the feasibility and safety of a urine alkalinization protocol for the prevention of
AKI in patients testing positive for COVID-19.